Opinion
T1 Miсah Riggs, on behalf of his mother-in-law, the decedent Vickie Warren, 1 appeals the trial court's decision that the Comparative Negligence Act (CNA), and therefore joint and several liability, did not apply in this case. Defendant Union Carbide Corporation eross-appeals, arguing that its motion for judgment notwithstanding the verdict was wrongly denied because the raw material supplier rule shields Union Carbide from liability under the facts of this case. Aiterna-tively, Union Carbide argues in its cross-appeal that there was insufficient evidence to support the jury's verdict that the unique type of asbestos it supplied medically caused Warren's illness. Defendant Georgia-Pacific, LLP also cross-appeals, challenging the sufficiency of the evidence identifying a particular Georgia-Pacific product at the various construction sites where Warren was exposed to asbestos. We affirm.
BACKGROUND
12 "On appeal, we recite the facts from thе record in the light most favorable to the jury's verdict." Smith v. Fairfax Realty, Inc.,
T3 Georgia-Pacific's involvement in this case arises from its role as a manufacturer and consumer-side supplier of asbestos-containing tape joint compound that was used at various residential construction sites where Warren helped her father from 1958 through 1977 and in the construction of Warren's own home in 1977. 4 Union Carbide intermittently supplied the raw asbestos, a unique variety called Calidria, 5 that was used by Georgia-Pacific in the manufacturing of its tape joint compound between 1970 and 1977.
T4 "On the eve of trial," during a pretrial conference with all of the parties, Warren argued for the first time that the CNA, rather than the Liability Reform Act (LRA) that the parties had been proceeding under for the entire three years since the filing of the case, ought to apply because it was in effect at the time of Warren's exposure to Defendants' asbestos and asbestos-containing products. The trial court rejected Warren's argument, determining that the LRA applies both because Warren did not have a causе of action until she was diagnosed with mesothe-lioma and because her argument was untimely.
15 A jury trial was held in April and May 2010, at the conclusion of which both Georgia-Pacific and Union Carbide moved for a directed verdict, arguing, among other things, that Warren failed to prove that her illness was medically caused by their products. The trial court denied the directed verdict motions, noting, "[This is the most fact-intensive and expert-intensive trial that I've ever presided upon, and the issues will remain for jury determination...."
T 6 The jury reached its verdiet on May 12, 2010, awarding Warren $5,256,818.61 in economic and non-economic damages. The jury, having been instructed to apportion fault in accordance with the LRA, determined that Georgia-Pacific was 5% at fault and Union Carbide 20% at fault. 6
T7 Almost one year later, Union Carbide moved for judgment notwithstanding the verdict (the JNOV motion), reasserting an argument that it first made in its pretrial motion for summary judgment-that it could not be held liable for Warren's illness because it is a bulk supplier of raw materials, as described in the Third Restatement of Torts. See Restatement (Third) of Torts: Products Liability § 5 & emt. c (1998). The trial court had rejected this argument when it denied Union Carbide's motion for summary judgment, reasoning that "Utah has not considered the issue of adopting the Restatement (Third) of Torts: Products Liability § 5 and, indeed, recent Utah case law supports the conclusion that with respect to the specific provision at issue ..., the Restatement (Second) of Torts should act as the guide," and the court ulti
Union Carbide is a raw materials supplier. They mined and milled asbestos and they put it in bags.... And they sold this asbestos to manufacturers.
The manufacturers then decided what to do with the asbestos, whether to use it, how much to use, what to mix it with, how to package it, and what to put on those packages.
[[Image here]]
... Union Carbide didn't sell a bag of asbestos to Ms. Warren....
Onee that asbestos is packaged, ... [and sent] to a distributor[,] Union Carbide is no{ longer] involved.... That's not Union Carbide's area of responsibility. It's almost like taking a baton in a relay race[ in that]) Union Carbide starts out with the raw fiber, ... [and] passes [it] on ... [to] a distributor, [who mixes and repackages it and has its own] ... areas of responsibility.
... Union Carbide takes responsibility for where it fits into this whole process.
The issue was raised again at a hearing on jury instructions, during which Union Carbide noted, "[Wle would concede that [the court] has ruled on the [bulk supplier argument] and we are asserting it simply for the record...." Union Carbide raised this argument a final time during trial in closing argument, by asking the jury to "[rlemember [it was] a raw supplier" and, as such, had the ability to warn only its direct customers about the dangers of asbestos because "when [it] put a warning on a bag, that bag goes to a manufacturer and that bag is gone."
18 Union Carbide's JNOV motion renewed this argument, relying on the Utah Supreme Court's explicit adoption of most of section 5 of the Third Restatement of Torts in a case that was issued two days after the jury reached its verdict in Warren's case. See Gudmundson v. Del Ozone,
ISSUES AND STANDARDS OF REVIEW
T9 Warren asserts that the trial court erroneously applied the LRA instead of the CNA. This presents a question of law, which we review for correctness. Jedrziewski v. Smith,
T 10 Union Carbide argues on cross-appeal that the bulk supplier rule exempts it from liability. We interpret this as an appeal from the denial of its JNOV motion. Union Carbide also asserts that its directed verdict and JNOV motions were wrongly denied because Warren presented insufficient evidence of medical causation to support the jury's verdict.
7
A motion for judgment notwithstanding the verdict or a motion for a directed
1 11 Georgia-Pacific also cross-appeals, arguing that its directed verdict motion was wrongly denied because the jury's verdict was not supported by sufficient evidence as to the identification of its tape joint compound at any of the locatiоns where Warren was exposed to asbestos-containing tape joint compound. We review the trial court's denial of a motion for directed verdict considering "the evidence and all reasonable inferences that may fairly be drawn therefrom in the light most favorable to the party moved against, and will sustain the denial if reasonable minds could disagree with the ground asserted for directing a verdict." Mahmood v. Ross,
ANALYSIS
I. Applicability of the LRA
112 Warren argues that the LRA was wrongly applied because her cause of action arose when she was exposed to asbestоs, not when she was diagnosed with meso-. 8 The trial court disagreed, concluding that Warren's claim did not acerue until she was diagnosed with mesothelioma and that the LRA applies because it was the law in effect at that time. We agree with the trial court.
118 "The general rule is that the law establishing substantive rights and liabilities when a cause of action arises, and not a subsequently enacted statute, governs the resolution of the dispute." Carlucci v. Utah State Indus. Comm'n,
14 "A tort cause of action accrues when it becomes remediable in the courts, that is, when all elements of a cause of action come into being." Davidson Lumber Sales, Inc. v. Bonneville Inv., Inc.,
15 Here, Warren argues that her claim accrued "long before" the LRA became effective because her "initial injury" was the cell dаmage and searring that resulted from inhaling Defendants' asbestos. We disagree. Regardless of whether the replication of those damaged cells over time produced Warren's cancer, see infro ¶¶ 27-28, she nonetheless did not have an actionable claim until she was diagnosed with mesothelioma. Until then, Warren's development of meso-thelioma was only a possibility in light of her exposure to asbestos. Indeed, it is the same possibility that any of her family members, who also worked alongside Warren at the same construction sites during the same period of time, could have developed an asbestos-related illness. See Hansen v. Mountain Fuel Supply Co.,
II. The Raw Materials Supplier Rule
116 Union Carbide argues on cross-appeal that its JNOV motion was incorrectly denied because under the Third Restatement of Torts, "a raw material supplier ... cannot be held liable for injuries to end users of tape joint compound." The trial court denied the JNOV motion without explicitly addressing this argument, noting simply that there was sufficient evidence to support the jury's verdict.
17 Generally, "[tlrial courts may grant a j.n.o.v. only when the losing party is entitled to judgment as a matter of law. Accordingly, we will affirm a jn.owv. only when the evidence is insufficient as a matter of law to support the jury's verdict." Walker v. Parish Chem. Co.,
€18 Two days after the jury reached its verdiet in this case, our supreme court, in Gudmundson v. Del Ozone,
"One engaged in the business of selling or otherwise distributing product componеnts who sells or distributes a component is subject to liability for harm to persons or property caused by a product into which the component is integrated if:
[[Image here]]
(b)(1) the seller or distributor of the component substantially participates in the integration of the component into the design of the product; and
(2) the integration of the component causes the product to be defective, as defined in [the Restatement]; and
(3) the defect in the product causes the harm."
Id. 155 (quoting Restatement (Third) of Torts: Products Liability § 5 (1998)); see also id. ¶ 55 n. 14 (declining to adopt subsection (a) of the Restatement provision at issue because "it only addresses situations in which the component part itself is defective" and those situations are already "adequately addressed in our case law"). The supreme court explained that this new rule "embraces the policy-based rationale that although manufacturers of nondefective component parts at the time of sale should not bear the risk оf ensuring the integrated product's safety, a component manufacturer who participates in the design of the product should bear some liability risk." Id. 156; accord Restatement (Third) of Torts: Products Liability § 5 emt. a.
119 The rule defines "[pJroduct components" as "raw materials, bulk products, and other constituent products sold for integration into other products." Restatement (Third) of Torts: Products Liability § 5 emt. a. Liability for a nondefective product under the rule "requires two findings. First, the participation [by the component supplier in integrating the component into the final product] must be substantial. Second, the integration of the nondefective component must cause the integrated product to be defective." Gudmundson,
120 In applying the Gudmundson rule to this case, the first step is to determine whether Union Carbide's product, Calidria, was defective; the bulk supplier defense is available only to supplier's of nondefective products. "Utah law recognizes three types of product defects: design defects, manufacturing flaws, and inadequate warnings regarding use." House,
121 Here, Warren argues that the hazards posed by raw asbestos, in general, render asbestos innately defective. We disagree with this "dangerous equals defective" argument and determine that, regardless of its dangerousness, Union Carbide's product could not be defectively designed or manufactured because it is a raw, unadulterated material.
11
- See Restatement (Third) of Torts: Products Liability § 5 emt. c ("[A] basic raw material ... cannot be defectively designed."); see also Cimino v. Raymark Indus., Inc.,
122 Thus, the question boils down to whether Calidria was defective based on the adequacy of the warnings provided. Implicit in evaluating whether a warning was defective is the need to identify "the ordinary and prudent buyer, consumer, or user of that product" to whom the notice was due. See Niemela,
24 Additionally, Warren did not address at trial whether Union Carbide's duty to warn applied exclusively to Georgia-Pacific or extended to Warren and, to an extent, had little reason to do so in light of the trial court's earlier ruling rejecting the application of the bulk supplier rule and the generalities used by Union Carbide in its pretrial proposed jury instructions. Thus, we find ourselves in the peculiar procedural position of reviewing a denial of a judgment notwithstanding the jury's verdict, when the issue at hand, while persuasive at an abstract level, was not presented to the jury and therefore not a part of its verdict. Because we arе constrained by the JNOV standard, we must affirm the trial court's determination. Thus, Union Carbide has demonstrated that the bulk supplier rule generally applies in cases like this one but has failed to show that the evidence before the jury requires a conclusion, as a matter of law, that it had fulfilled whatever duty to warn it had under the cireumstances, even if that duty extended only to Georgia-Pacific and not to Warren."
III. Sufficiency of the Evidence
1 25 Last, we address Union Carbide's and Georgia-Pacific's cross-appeals, challenging
A. Union Carbide's Challenge to the Sufficiency of the Evidence
{26 Union Carbide's insufficiency argument is framed as an appeal from the trial court's denial of its directed verdict and JNOV motions. We review both denials for correctness and will reverse "when the evidence is insufficient as a matter of law to support" a verdict against the moving party. See Walker v. Purish Chem. Co.,
127 Union Carbide argues that Warren failed to prove that "Calidria ... causes peritoneal mesothelioma" in general and that Calidria "more probably than not . was a substantial factor in causing her peritoneal mesothelioma." - In support of this argument, Union Carbide claims that Warren's lead medical expert, Dr. Samuel Ham-mar, admitted that his causation testimony was based on an "'unproven hypothesis." This argument revolves around Dr. Ham-max's testimony that mesothelioma is a dose-response disease-meaning the more exposures a pеrson has to asbestos, the more likely they are to develop mesothelioma. Union Carbide's description of Dr. Hammar's conclusion, however, is taken out of context; Dr. Hammar's answer to Union Carbides question at trial as to whether this dose-response theory was an unproven hypothesis is more nuanced than Union Carbide acknowledges. Dr. Hammar actually stated, "[With respect to [Union Carbide's] question about [whether] 'that's an unproven hypothesis, I think, in a way, it is proven." Dr. Hammar further explained that although the dose-response hypothesis itself may not be the subject of a research paper, textbook, or study, it is nonetheless a fundamental understanding in the medical community as to how cancer develops. He testified that Union Carbide's framing of the question misrepresented the issue in that the dose-response hypothesis may never be definitively "proven" because to do so would require "actually look{[ing] inside of a person's рleura ... [to] see what kind of changes are happening at a given time ... [and] get[ting] multiple biopsies" to run genetic tests over a period of "many years" before seeing "the development of a single cancer cell." That it cannot be proven either way, Dr. Hammar testified, is not evidence that the theory is incorrect.
{28 Union Carbide also claims that Dr. Hammar stated that he did not know whether there was any evidence that Calidria could have caused Warren's disease and that he agreed there was no evidence that Calidria could cause mesothelioma in general This summary of Dr. Hammar's testimony is also taken out of context. Although Dr. Hammar testified that he believed there was not yet "a documented case that Calidria has caused mesothelioma," he qualified his answer by explaining "that [there are no documented cases in which] ... the only asbestos [meso-thelioma patients] were exposed to was the Calidria chrysotile asbestos." In addition, Dr. Hammar testified that because mesothe-lioma is a dose-response disease, there is no way "to go back in a specific person's work history who gets mesothelioma" and pinpoint a particular exposure as the cause, especially because "[alll types of asbestos can cause mesothelioma" and "most of the people that have been exposed to asbestos have been exposed to more than one type," with the "combination of chrysotile and amphiboles ... produc[ing] the most cases of mesothelio-ma." This concept is well documented in the medical literature, according to Dr. Hammar, and supported by Warren's other expert medical witness as well as at least one of Union Carbide's expert medical witnesses, who also was involved in publishing a study that claimed that all types of asbestos cause
T29 Last, Dr. Hammar's testimony that he could not say that Calidria alone caused Warren's mesothelioma was given in the context of his explanation that because Warren, like most people, was exposed to more than one type of asbestos, it is impossible to single out any one type of asbestos as the stand-alone cause of her disease. And here, Wаrren did not need to provide evidence that Calidria was the sole cause of her illness but only that it was a substantial factor. Dr. Hammar testified that chrysotile asbestos, and, more specifically, Warren's exposures to tape joint compound dust, caused Warren's mesothelio-ma, necessarily leading to the conclusion that Calidria contributed to her illness because Calidria is the type of chrysotile asbestos contained in the tape joint compound at issue. Dr. Hammar based that conclusion on his research demonstrating that chrysotile asbestos has "a tendency to damage ... cells and make changes in ... cells more than the other types of asbestos" as well as a greater likelihood of "translocat{ing] from the lung . to the [peritoneum]." Warren's other medical expert witness agreed, explaining that Calidria, specifically, can cause the cell damage that leads to mesothelioma. Accordingly, Warren presented sufficient evidence for the jury to determine that Calidria was a substantial factor in causing her illness. Though Union Carbide presented evidence to the contrary and attempted to discredit and refute Warren's evidence, "this criticism does not conclusively prove the invalidity of" Warren's evidence, see Boyd v. Celotex Corp.,
B. Georgia-Pacific's Challenge to the Sufficiency of the Evidence
130 On cross-appeal, Georgia-Pacific challenges the trial court's denial of its motion for directed verdict, arguing that Warren produced insufficient evidence to prove that she was actually exposed to its brand of tape joint compound. Georgia-Pacific claims that the evidence Warren pre
181 "This [clourt's standard of review of a directed verdict is the same as that imposed upon the trial court." Mahmood v. Ross,
132 Here, Georgia-Pacific contends that Warren's evidence failed to sufficiently identify its tape joint compound as being used, not just present, at any particular work site where Warren was exposed to asbestos from tape joint compound dust and that, as a result, she failed to show that Georgia-Pacific's product was a cause of her illness. The jury instructions explained that for the different claims Warren alleged, causation hinged on determining whether Warren's "exposure to a particular defendant's asbestos or asbestos-containing product," a defect in the design of a defendant's product, or a defendant's lack of adequate warning were, individually, substantial factors behind Warren's having developed peritoneal mesotheli-oma. - Georgia-Pacific marshals the evidence 16 as follows: Warrеn's brother-in-law testified that he remembered carrying boxes of tape joint compound into a duplex project that Warren's family was working on and into Warren's home while it was being built and that he believed those boxes of tape joint compound were probably from Georgia-Pacific. Warren's younger brother, who also started helping at their father's construction sites as a child, testified that Georgia-Pacific's tape joint compound was used at approximately 20% of his father's construction projects; he described the packaging for Georgia-Pacific tape joint compound as a white cardboard box with "GP" printed on it and "Georgia-Pacific" written below that in smaller letters; he identified two specific duplex projects where he recalled Georgia-Pacific tape joint compound being used; and he testified that Warren visited the duplex sites during construction from time to time and was there to help with сleanup after the drywall work was finished.
T83 Although not reflected in the quoted record excerpts in Georgia-Pacific's brief, the record pages that Georgia-Pacific cites also indicate that the descriptions Warren's brother and brother-in-law gave of Georgia, Pacific's tape joint compound packaging were nearly identical-both described the packaging as twelve-inch-by-twelve-inch white boxes with plastic lining on the inside-which lends credence to both of their testimonies. Additionally, both witnesses indicated that Georgia-Pacific's tape joint compound was used during the construction of at least one of the duplex projects, and both testified that Warren helped with cleanup work at the duplex projects. Warren's brother specifically remembered Warren helping clean up at the duplex project after the drywall work was finished, i.e., cleaning up tape joint compound dust. Further, while only onе of these two witnesses recalled Georgia-Pacific tape joint compound being used in the construction of
134 Construing this evidence, which amounts to only a snapshot of what was presented аt trial, in a light most favorable to Warren, Warren has demonstrated that she did cleanup work that most often involved sweeping asbestos-containing dust from tape joint compound at her father's work sites, which 20% of the time used Georgia-Pacific tape joint compound, and that she did this for an average of nine to twelve hours per week for nineteen years in addition to the time she spent at her own home cleaning up tape joint compound dust and sanding 50% of the tape joint compound herself, some of which was also CGeorgia-Pacific's tape joint compound. In addition, at all relevant times, Georgia-Pacific's tape joint compound contained asbestos.
1 35 Next, we consider this evidence under the predominant view of the medical community, as simplified (immensely) by Georgia-Pacific at oral arguments, that a person does not develop asbestos-caused peritoneal meso-thelioma without having frequent, regular, and proximate exposures to asbestos. Here, the evidence is sufficient to demonstrate just that. Whether Warren's evidence is to be believed over conflicting evidence that was also presented at trial is not relevant for our analysis where the standard requires a showing of no competent evidence. See Nixdorf v. Hicken,
CONCLUSION
136 The trial court was correct in detеrmining that the LRA, rather than the CNA, applied in this case. We affirm the trial court's denials of Union Carbide's JNOV motion and Georgia-Pacific's directed verdict motion. 18
Notes
. - For simplicity, we refer to the Appellant/Cross-Appellee as Warren, rather than Riggs.
. Peritoneal mesothelioma affects the peritoneum, which is the membrane that lines the walls of the abdominal cavity. See Web MD, Mesothe-lioma, http://www.webmd.com/cancer/ mesothelioma-11211 (last visited March 29, 2013).
. Hamilton Materials is not a party to this appeal,
. As the Defendants explain, "[jJoint compound is an adhesive that performs several functions in construction work, including attaching the joint tape placed over seams between sheets of drywall and concealing nail heads." If joint compound is applied io surfaces that are "to be 'finished' (in the construction sense), it is sanded so that the area will present a smooth surface for painting." As concerns these defendants, Warren was exposed to asbestos when she inhaled the dust produced from sanding tape joint compound at the various construction sites where she was present from 1958 to 1977.
. Union Carbide explains in its appellate brief that the term " 'asbestos' covers a family of naturally occurring silicate minerals with a fibrous structure."
. Hamilton Materials and other parties not relevant to this appeal were apportioned 12% and 63% of the fault respectively.
. We assume Union Carbide raises the bulk supplier issue as an appeal from the denial of its JNOV motion, as it does for its causation argument. - In laying out its bulk supplier argument on appeal, Union Carbide references its summary judgment, directed verdict, and JNOV motions to demonstrate that the argument was preserved, without stating from which denial it is appealing. Because Union Carbide's summary judgment motion was denied on November 9, 2009, and its directed verdict motion was denied on May 7, 2010-both before Gudmundson was issued on May 14, 2010-it does not appear that Union Carbide intеnded to nonetheless appeal the denial of these two motions based on the applicability of the bulk supplier rule when this rule was not explicitly part of Utah law at the time those motions were denied. See generally Gudmundson v. Del Ozone,
. Warren also argues that the trial court erroneously rejected her motion as untimely. Because of the manner in which we resolve this issue, we need not address the question of timeliness.
. We note that the determination of which statute applies has a major impact on all parties in that the CNA permitted joint and several liability, while the LRA renders a defendant liable for only the proportion of the damages that is commensurate with the proportion of its fault. See Stephens v. Henderson,
. Although Gudmundson is discussed extensively in their briefs, the parties have not addressed whether this decision ought to be applied retroactively in this case. See generally Merrill v. Utah Labor Comm'n,
. Warren insists that Calidria was "manufactured" based on one Union Carbide witness whose testimony stated that the company "manufactured different grades of asbestos fiber" by essentially cleaning the raw fibers to varying levels of purity. (Emphasis omitted.) However, Warren has not asserted that this process was conducted defectively or that it somehow made the raw asbestos "unreasonably dangerous" beyond its inherent qualities. Cf. Bishop v. GenTec Inc.,
. Union Carbide's evidence indicates that it began placing warnings on the packaging for Calid-ria starting in June 1968, which was four years before such warnings were federally mandated. The 1968 warning read, "WARNING: BREATHING DUST MAY BE HARMFUL DO NOT BREATHE DUST." After the warnings were mandated, Union Carbide updated the language of the warning to read, "CAUTION Contains Asbestos Fibers Avoid Creating Dust Breathing Asbestos Dust May Cause Serious Bodily Harm," and also provided an "Asbestos Toxicology Report" to customers that explained the potential health risks of asbestos inhalation and recommended different control methods to make working with asbestos safer. The report was revised regularly to stay current with developments in the understanding of asbestos's effect on the body. The revised reports pointed out the association between asbestos and mesothelioma and recommended that рeople "wear respirators where dusting occurs in finishing products such as sanding taped joints." (Internal quotation marks omitted.) Union Carbide also offered its assistance to its customers to conduct dust counts in their facilities to determine "what the level of airborne asbestos was," and provided its customers with an index of asbestos regulations and scientific and medical literature regarding the potential health risks associated with asbestos.
. Had Union Carbide filed a motion for a new trial and appealed from the denial of that, we would have been able to apply a broader standard of review. See supra ¶ 10 n. 7. Compare Walker v. Parish Chem. Co.,
. Union Carbide directs our attention to other jurisdictions that have rejected various applications of this "every fiber hurts" theory. What occurred in these cases, however, was not blanket rejections of the "every fiber hurts" theory. See, eg., Boyd v. Celotex Corp.,
. Because we determine that Dr. Hammar's testimony and the evidence regarding Warren's exposures to tape joint compound dust containing Calidria are sufficient to support the jury's verdict, we do not address Union Carbide's challenges to Warren's other causation evidence. Additionally, Union Carbide's causation challenges are arguably not properly marshaled. See generally Hansen v. Stewart,
. We disagree with Warren's argument that Georgia-Pacific failed to meet its marshaling burden. See generally West Valley City v. Majestic Inv. Co.,
. Warren helped at various construction sites from 1958 to 1977. Her brother testified that he started helping sometime around 1966 or 1969, when he was between five and eight years old.
. We deny Warren's request for costs on appeal because she did not prevail on the issue she appealed. See generally Utah R.App. P. 34(a).
